Skip to main content

Table 3 The distribution and odds ratio for palliative vs an intended curative aim of the operation among operated colorectal cancer (CRC) patients, and for oncological treatment for colon and rectum cancer by pre-existing psychiatric history

From: Colon cancer patients with a serious psychiatric disorder present with a more advanced cancer stage and receive less adjuvant chemotherapy - A Nationwide Danish Cohort Study

Study population, (N) -number with information available

Cancer procedure

Patients with psychiatric disordera

n (%)

Patients without psychiatric disordersa

n (%)

Crude OR (95% CI), (reference no psychiatric disorder)

Adjusted OR b (95% CI) (reference no psychiatric disorder)

Cohort 1

All CRC

(22,010 with information)

 Aim of the operative treatmentc

  Curative

308 (72.99)

19,392 (78.28)

  

  Palliative

38 (9.00)

2272 (9.17)

1.05 (0.75–1.48)

0.93 (0.62–1.39)

  Missing

76 (18.01)

3108 (12.60)

  

Cohort 2

Colon cancer

(16,641)

 Oncological treatmentd

    

  No

193 (64.12)

9519 (58.26)

  

  Yes

108 (35.88)

6821 (41.74)

0.78 (0.62–0.99)

0.55 (0.40–0.76)

Cohort 3

Rectum cancer

(8553)

 Oncological treatmentd

  No

64 (52.89)

4011 (47.57)

  

  Yes

57 (47.11)

4421 (52.43)

0.81 (0.56–1.16)

0.72 (0.46–1.11)

  1. aPsychiatric disorder cases = having had a history of hospital admission for at least one psychiatric diagnosis as the primary diagnosis according to ICD-10-criteria: DF20–29: primary psychotic disorders, and DF30–39: affective disorders in the time period from 10 years to 120 days prior to the colorectal cancer operation
  2. bOdds ratio (OR) with 95% confidence interval (CI), adjusted for age, gender, Charlson Comorbidity Index score, cancer stage at the time of operation, educational level, socio-economic position
  3. cCurative or intended palliative aim of the operative treatment among colon and rectal cancer patients combined regardless of acute or not
  4. dOncological treatment = Received at least one oncological treatment (chemotherapy or radiotherapy), by cancer site